Tag: ANDAs
Zydus posts consolidated revenues of Rs. 3655 crores in Q3
The company filed 12 additional ANDAs with the USFDA during the quarter and received 9 new product approvals (including 5 tentative approvals) from the USFDA.
Panacea Biotec announces joint collaboration with Biopharma Inc
Under the collaboration, Panacea Biotec will be responsible for manufacturing and supply of the new drug entities of Biopharma Inc which again will be a distributor of these ANDAs in the United States and its territories..........